论文部分内容阅读
瑞典当局已批准了托特罗定（tolterodine）用于治疗可引起尿失禁的膀脱不稳定性。与其它现行的治疗相比，Pharmacia＆Upjohn公司的托特罗定（商品名Detrusitol）能显著降低口干的发生率。有2600多例膀胱不稳定性患者参与的29组双盲随机研究证实，本品治疗尿失禁是安全有效的，?
Swedish authorities have approved tolterodine for the treatment of bladder instability that can cause urinary incontinence. Pharmacia & Upjohn’s Detrusitol significantly reduced the incidence of dry mouth when compared to other current treatments. There are more than 2600 cases of bladder instability in 29 patients involved in double-blind randomized study confirmed that the product is safe and effective treatment of urinary incontinence?